To analyse the effects of FAAP24 on survival across cancers, patients with 33 types of tumors were split into two different risk groups based on the median value of FAAP24 expression and analysed using the GEPIA2 database (Fig. 2A). This evidence concerns the gene FAAP24 and cancer.